Gilead Sciences (NASDAQ:GILD) Issues FY 2024 Earnings Guidance

Gilead Sciences (NASDAQ:GILD – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 3.600-3.900 for the period, compared to the consensus EPS estimate of 3.750. The company issued revenue guidance of $27.1 billion-$27.5 billion, compared to the consensus revenue estimate of $27.6 billion. Gilead Sciences also updated […]

Leave a Reply

Your email address will not be published.

Previous post Entain (LON:ENT) Trading Up 9.3% Following Dividend Announcement
Next post Fennec Pharmaceuticals Inc (NASDAQ:FENC) Expected to Earn Q2 2024 Earnings of ($0.17) Per Share